- Brand name: Haemocomplettan® P
- Generic name: Fibrinogen
- Indication:
- Therapy and prophylaxis of haemorrhagic diatheses in:
- Congenital hypo-, dys- or afibrinogenaemia
- Acquired hypofibrinogenaemia resulting from
- disorders of synthesis in cases of severe liver parenchyma damage
- increased intravascular consumption e.g. as a result of disseminated intravascular coagulation, hyperfibrinolysis
- increased blood loss
- The most important clinical pictures associated with a defibrination syndrome are: Obstetrical complications, acute leukaemia especially promyelocytic leukaemia, liver cirrhosis, intoxications, extensive injuries, haemolysis after transfusion errors, operative interventions, infections, sepsis, all forms of shock as well as tumours especially in the lung, pancreas, uterus, and prostate.
- Dosage form: Powder for solution for injection/infusion, Vial, 1g
- Manufacturer: CSL Behring GmbH
- Country of origin: Germany
